MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Memory disorders"

  • 2018 International Congress

    The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson’s disease and analysis of relevant factors

    K. Nie, Y. Gao, M. Mei, M. Guo, Z. Huang, L. Wang, J. Zhao, Y. Zhang, L. Wang (Guangzhou, China)

    Objective: To investigate the clinical characteristics, cognitive impairment features, and subgroup types of Parkinson’s disease (PD) patients with mild cognitive impairment and to analyze relevant…
  • 2018 International Congress

    Effect of different normative samples and cut-off values on determination of cognitive impairment in the Parkinson’s Progression Marker Initiative

    K. Wyman-Chick, D. Weintraub, P. Martin, L. Erickson, M. (Saint Paul, MN, USA)

    Objective: Compare cognitive performance in participants with Parkinson Disease (PD) utilizing published normative data versus age-stratified norms from the Parkinson’s Progression Marker Initiative (PPMI) healthy…
  • 2018 International Congress

    Hypertriglyceridemia is associated with Parkinson disease mild cognitive impairment (PD-MCI)

    S. Ng, KY. Tay, X. Huang, NSY. Chia, S. Archaryya, F. Setiawan, ZH. Lu, J. Tan, YL. Ng, MC. Wen, A. Ng, W. Au, EK. Tan, L. Tan (Singapore, Singapore)

    Objective: Our study aimed to characterise Parkinson disease (PD) mild cognitive impairment (PD-MCI) in early PD and to identify biomarkers associated with PD-MCI. Background: Approximately…
  • 2018 International Congress

    Diagnostic accuracy and imaging correlates of the Free and Cued Selective Reminding Test for screening mild cognitive impairment in Parkinson’s disease

    J. Pagonabarraga, A. Horta-Barba, J. Marín-Lahoz, S. Martinez-Horta, H. Bejr-Kasem, I. Aracil, J. Pérez-Pérez, B. Pascual-Sedano, J. Kulisevsky (Barcelona, Spain)

    Objective: To assess the diagnostic accuracy of FCSRT for screening mild cognitive impairment in PD (PD-MCI), and to correlate FCSRT scores with gray and white…
  • 2018 International Congress

    The Effect of Sleep Deprivation on Short-Term Memory and Emotion of Rotenone Treated Zebrafish Model of Parkinson Disease

    Y. Xiong, D. Lv, S. Wei, F. Wang, C. Liu (Suzhou, China)

    Objective: We investigated the long-term consequences of sleep deprivation on short-term memory and emotion using a rotenone treated zebrafish model of Parkinson disease. Background: Parkinson…
  • 2018 International Congress

    Serum Uric Acid Level and Its Relationship to Non-Motor Symptomatology in Parkinson’s disease

    O. Odeniyi, N. Okubadejo, O. Ojo, M. Danesi (Lagos, Nigeria)

    Objective: To determine the relationship between serum uric acid level and non-motor symptoms using the PD specific non-motor symptoms in Nigerian patients with Parkinson’s disease.…
  • 2017 International Congress

    Goalkeeper game: a novel test to identify early implicit learning alterations in people with Parkinson’s disease

    M.E. Pimentel Piemonte, A. Galves, A. Frazao Helene, M. D'Alencar (Sao Paulo, Brazil)

    Objective: To investigate the efficacy of a novel videogame to identify the early alterations in implicit learning (IL) in people with PD (PPD) Background: Although…
  • 2017 International Congress

    Difficulties in executing the MDS recommendations in the brazilian population

    E. Carreira, E. CARREIRA, A. PRADO, N. BRAZ, F. TAVARES, N. ROCHA, L. DE SOUZA, F. CARDOSO, A. TEIXEIRA (Belo Horizonte, Brazil)

    Objective: To investigate the usefulness of the trail making test (TMT)-A and TMT-B in the cognitive evaluation of a Brazilian sample of patients with PD.…
  • 2017 International Congress

    Cognitive data in the Parkinson’s Progression Markers Initiative: Comparison of normative data approaches

    K. Wyman-Chick, M. Barrett, P. Martin, C. Manning, S. Sperling (Charlottesville, VA, USA)

    Objective: It is important to understand underlying psychometric properties of the cognitive tests included in the Parkinson’s Progression Markers Initiative (PPMI) dataset to interpret the…
  • 2017 International Congress

    Predictor of progressive mild cognitive impairment in patients with Parkinson’s disease.

    Y. Tajiri, K. Wada-Isoe, M. Hamada, M. Sawada, K. Nakashima (Yonago, Japan)

    Objective: To clarify clinical features of patients with progressive mild cognitive impairment patients (MCI) in Parkinson’s disease (PD-MCI). Background: Non-demented PD subjects have MCI and…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley